感染性坏死性胰腺炎内镜与外科阶梯式治疗(ExTENSION):随机试验长期随访
该研究对TENSION试验中98例感染性坏死性胰腺炎患者中仍存活的83例进行至少5年长期随访,比较内镜与外科阶梯式治疗。平均随访7年,主要终点(死亡和主要并发症复合终点)内镜组27例(53%)与外科组27例(57%)无显著差异(RR 0.93,95%CI 0.65-1.32,P=0.688);内镜组胰腺皮肤瘘更少(8% vs 34%;RR 0.23,95%CI 0.08-0.83),初始6个月随访后再次干预更少(7% vs 24%;RR 0.29,95%CI 0.09-0.99)。
要点
- 长期随访中内镜阶梯式治疗在死亡或主要并发症方面未优于外科阶梯式治疗(RR 0.93,95%CI 0.65-1.32)。
- 内镜组胰腺皮肤瘘发生率低于外科组(8% vs 34%;RR 0.23,95%CI 0.08-0.83)。
- 初始6个月随访后内镜组再次干预少于外科组(7% vs 24%;RR 0.29,95%CI 0.09-0.99)。
核心结论
- 长期随访中,内镜阶梯式治疗在减少感染性坏死性胰腺炎患者死亡或主要并发症方面未优于外科阶梯式治疗。
- 然而,内镜组总体胰腺皮肤瘘更少,且初始6个月随访后需要再次干预更少。
研究设计与样本
- 本研究为TENSION随机对照试验的长期随访研究,重新评估了初始6个月随访后仍存活的83例患者(原始纳入98例)的全部临床资料。
主要发现
- 平均随访7年,主要终点(死亡和主要并发症复合终点)在内镜组发生于27例(53%),在外科组发生于27例(57%)(RR 0.93;95%CI 0.65-1.32;P=0.688)。
- 内镜组胰腺皮肤瘘发生率低于外科组(8% vs 34%;RR 0.23;95%CI 0.08-0.83)。
- 初始6个月随访后,内镜组再次干预少于外科组(7% vs 24%;RR 0.29;95%CI 0.09-0.99)。
- 胰腺功能不全和生活质量在两组间无差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Previous randomized trials, including the Transluminal Endoscopic Step-Up Approach Versus Minimally Invasive Surgical Step-Up Approach in Patients With Infected Pancreatic Necrosis (TENSION) trial, demonstrated that the endoscopic step-up approach might be preferred over the surgical step-up approach in patients with infected necrotizing pancreatitis based on favorable short-term outcomes. We compared long-term clinical outcomes of both step-up approaches after a period of at least 5 years. METHODS: In this long-term follow-up study, we reevaluated all clinical data on 83 patients (of the originally 98 included patients) from the TENSION trial who were still alive after the initial 6-month follow-up. The primary end point, similar to the TENSION trial, was a composite of death and major complications. Secondary end points included individual major complications, pancreaticocutaneous fistula, reinterventions, pancreatic insufficiency, and quality of life. RESULTS: After a mean follow-up period of 7 years, the primary end point occurred in 27 patients (53%) in the endoscopy group and in 27 patients (57%) in the surgery group (risk ratio [RR], 0.93; 95% confidence interval [CI], 0.65-1.32; P = .688). Fewer pancreaticocutaneous fistulas were identified in the endoscopy group (8% vs 34%; RR, 0.23; 95% CI, 0.08-0.83). After the initial 6-month follow-up, the endoscopy group needed fewer reinterventions than the surgery group (7% vs 24%; RR, 0.29; 95% CI, 0.09-0.99). Pancreatic insufficiency and quality of life did not differ between groups. CONCLUSIONS: At long-term follow-up, the endoscopic step-up approach was not superior to the surgical step-up approach in reducing death or major complications in patients with infected necrotizing pancreatitis. However, patients assigned to the endoscopic approach developed overall fewer pancreaticocutaneous fistulas and needed fewer reinterventions after the initial 6-month follow-up. Netherlands Trial Register no: NL8571.
引用
- Onnekink AM, Boxhoorn L, Timmerhuis HC, et al. Endoscopic Versus Surgical Step-Up Approach for Infected Necrotizing Pancreatitis (ExTENSION): Long-term Follow-up of a Randomized Trial. Gastroenterology. 2022. PMID: 35580661. doi:10.1053/j.gastro.2022.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。